Last reviewed · How we verify

NCT05171543

Effect of Combined Use of an Allograft and Membrane on the Healing Outcome of Apicomarginal Defects

Status unknown NA Last updated 29 December 2021
What this trial tests

NA trial testing Periapical surgery with placement of an allograft and a membrane in Apicomarginal Defects in 30 participants. Status unknown.

Timeline
1 February 2021
Primary endpoint
1 May 2022
1 May 2022

Quick facts

Lead sponsorPostgraduate Institute of Dental Sciences Rohtak
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment30
Start date1 February 2021
Primary completion1 May 2022
Estimated completion1 May 2022
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Who can join

Adults 16 to 60, any sex, with Apicomarginal Defects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healing of apicomarginal defects using 2 different groups, one being treated with the use of an allograft and a membrane and a control group, will be assessed and compared using 2D and 3D criteria. Also,quality of life will be compared between the two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Apicomarginal Defects

Currently open trials in the same condition.

Other Postgraduate Institute of Dental Sciences Rohtak trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05171543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing